← Back to Search

TMS for Post-Traumatic Stress Disorder

N/A
Waitlist Available
Led By Norman B Schmidt, PhD
Research Sponsored by Florida State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Over 18 years of age
Report clinically significant posttraumatic stress disorder (PTSD) symptoms (score of ≥ 33 on the PTSD Checklist for DSM-5 [PCL-5]).
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 hours
Awards & highlights

Study Summary

This trial tests whether PTSD patients have difficulty controlling their thoughts & emotions, & how this affects their mental health.

Who is the study for?
This trial is for adults over 18 with significant PTSD symptoms, who have experienced a traumatic event. It's not suitable for those with metal in their head, seizure disorders, brain tumors, strokes, aneurysms, multiple sclerosis or unstable medical conditions. People with OCD as a primary diagnosis or active substance use issues are also excluded.Check my eligibility
What is being tested?
The study is examining the effects of Transcranial Magnetic Stimulation (TMS) on cognitive control deficits in individuals suffering from PTSD. TMS is a non-invasive procedure that uses magnetic fields to stimulate nerve cells in the brain.See study design
What are the potential side effects?
TMS may cause discomfort at the site of stimulation, headache, lightheadedness or tingling. In rare cases it can induce seizures or hearing loss if ear protection isn't used during treatment.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am over 18 years old.
Select...
I have severe PTSD symptoms based on a specific checklist score.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~5 hours
This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 hours for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Performance on emotional working memory task

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Intermittent theta burst stimulation to right dorsolateral prefrontal cortexExperimental Treatment1 Intervention
Participants will receive intermittent theta burst stimulation (iTBS) to the experimental target area, the right dorsolateral prefrontal cortex (rDLPFC)
Group II: Intermittent theta burst stimulation to vertex of the skullActive Control1 Intervention
Participants will receive intermittent theta burst stimulation (iTBS) to the active comparator area, the vertex of the skull
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial Magnetic Stimulation (TMS)
2018
Completed Phase 4
~570

Find a Location

Who is running the clinical trial?

Florida State UniversityLead Sponsor
202 Previous Clinical Trials
31,746 Total Patients Enrolled
Norman B Schmidt, PhDPrincipal InvestigatorDistinguished Research Professor
3 Previous Clinical Trials
311 Total Patients Enrolled
~24 spots leftby Jun 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top